Abstract
We performed high-dose loading (12 mg/kg every 12 h for 48 h; 4 doses total) of teicoplanin (TEIC) in patients with severe methicillin-resistant Staphylococcus aureus (MRSA) infections, with the goal of achieving target serum concentration (TEICc) ≥ 15 mg/l within 48 h of starting administration. The safety and effectiveness of the fixed, early-stage administration method were evaluated across a range of kidney dysfunction severity levels. TEIC high-dose loading was administered to 106 patients with MRSA infection from February 2010 to February 2013. After high-dose loading, maintenance doses based on therapeutic drug monitoring (TDM) of TEICc were administered via 30-min intravenous drips, every 24 h. Subjects were divided into 4 groups based on kidney function and renal replacement therapy (RRT) status for safety and effectiveness evaluation: group 1 (G1) did not undergo RRT and exhibited creatinine clearance (Ccr; ml/min/m(2)) >50, group 2 (G2) exhibited Ccr ≤ 50, group 3 (G3) underwent continuous RRT (CRRT), and group 4 (G4) underwent intermittent RRT (IRRT). TEICc was measured after 24, 48, 72, and 144 h, immediately before TEIC administration. Target TEICc was reached in all groups, and bacteriological effectiveness and u...Continue Reading
References
Jan 1, 1987·European Journal of Clinical Pharmacology·A Assandri, A Bernareggi
Jul 1, 1996·Intensive Care Medicine·J L VincentL G Thijs
Aug 26, 1998·International Journal of Antimicrobial Agents·A P Wilson
Oct 21, 1998·Therapeutic Drug Monitoring·A P MacGowan
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy·Federico PeaMario Furlanut
Jan 1, 1950·Cancer·W J YOUDEN
Mar 22, 2006·Intensive Care Medicine·Olivier MimozWilliam Couet
Aug 2, 2007·Therapeutic Drug Monitoring·Ryoichi YanoMikio Masada
Dec 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michael RybakDonald P Levine
Jan 9, 2009·Clinical Pharmacology and Therapeutics·J R Senior
May 5, 2009·The Journal of Antimicrobial Chemotherapy·Elspeth LamontAlison H Thomson
Jun 4, 2013·Biological & Pharmaceutical Bulletin·Kazuaki MatsumotoYasuo Takeda
Oct 11, 2013·Clinical Interventions in Aging·Tomohiro MizunoKatsunori Furuta
Jan 28, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Takashi UedaHiroki Ikeuchi
Citations
Mar 11, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideo KatoHiroshige Mikamo
Apr 30, 2016·International Journal of Clinical Pharmacy·Takafumi NakanoKoujiro Futagami
Jun 10, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T UedaT Kimura
Sep 4, 2018·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Keisuke KagamiKen Iseki
Apr 2, 2019·Clinical Pharmacology in Drug Development·Chika OgamiHideto To
Oct 15, 2019·Basic & Clinical Pharmacology & Toxicology·Hao LiQindong Shi
Aug 3, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Si-Ho KimKyong Ran Peck
May 21, 2020·Frontiers in Pharmacology·Liuliu GaoYang Wang
Oct 30, 2021·Basic & Clinical Pharmacology & Toxicology·Toshinori HiraiTakuya Iwamoto